Author: Mehta, Vikas; Goel, Sanjay; Kabarriti, Rafi; Cole, Daniel; Goldfinger, Mendel; Acuna-Villaorduna, Ana; Pradhan, Kith; Thota, Raja; Reissman, Stan; Sparano, Joseph A.; Gartrell, Benjamin A.; Smith, Richard V.; Ohri, Nitin; Garg, Madhur; Racine, Andrew D.; Kalnicki, Shalom; Perez-Soler, Roman; Halmos, Balazs; Verma, Amit
Title: Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System Cord-id: a662zibc Document date: 2020_5_1
ID: a662zibc
Snippet: Patients with cancer are presumed to be at increased risk from COVID-19 infection–related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19–positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies.
Document: Patients with cancer are presumed to be at increased risk from COVID-19 infection–related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19–positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies. Six of 11 (55%) patients with lung cancer died from COVID-19 disease. Increased mortality was significantly associated with older age, multiple comorbidities, need for ICU support, and elevated levels of D-dimer, lactate dehydrogenase, and lactate in multivariate analysis. Age-adjusted CFRs in patients with cancer compared with noncancer patients at our institution and New York City reported a significant increase in case fatality for patients with cancer. These data suggest the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. SIGNIFICANCE: COVID-19 in patients with cancer is associated with a significantly increased risk of case fatality, suggesting the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. This article is highlighted in the In This Issue feature, p. 890
Search related documents:
Co phrase search for related documents- logistic model and lung cancer patient: 1
- logistic regression and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- logistic regression and lung cancer patient: 1, 2
- logistic regression and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- logistic regression and lung hematologic: 1, 2, 3
- logistic regression and lung hematologic malignancy: 1
- logistic regression and lung malignancy: 1, 2, 3, 4
- logistic regression and lymphoblastic leukemia: 1
- logistic regression and lymphocyte platelet: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53
- logistic regression and lymphocyte platelet count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- low hemoglobin level and lymphocyte platelet: 1
- low hemoglobin level and lymphocyte platelet count: 1
- lung cancer and lymphoblastic leukemia: 1
- lung cancer and lymphocyte platelet: 1, 2
- lung cancer and lymphoma myeloma: 1, 2
- lung disease and lymphoblastic leukemia: 1, 2
- lung disease and lymphocyte platelet: 1, 2, 3
- lung disease and lymphocyte platelet count: 1, 2
- lung disease and lymphoma myeloma: 1
Co phrase search for related documents, hyperlinks ordered by date